All In MedTech

FDA Clearance Tracker · P140003-S110

Impella 2.5, Impella CP and CP with SmartAssist

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 27, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140003-S110
Device name
Impella 2.5, Impella CP and CP with SmartAssist
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Mar 28, 2023
Decided
Apr 27, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the Impella Real-World Surveillance of patients using Sodium Bicarbonate. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval orders for P140003/S088 and P170011/S035.

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.